Enovis (ENOV) Other Operating Expenses (2022)

Enovis (ENOV) posted quarterly Other Operating Expenses of $4.6 million for Q4 2022, up 571.79% quarter-over-quarter from -$975000.0 in Q3 2022.

Enovis (ENOV) Other Operating Expenses (2022) Analysis & Trends

Enovis (ENOV) has reported Other Operating Expenses for 1 consecutive years, with $4.6 million the latest figure, recorded in Q4 2022.

In Q4 2022, Other Operating Expenses changed N/A year-over-year to $4.6 million; the TTM figure through Sep 2023 stood at $4.6 million (down 85.65% YoY), while the FY2022 annual figure was $36.7 million, changed N/A from the prior year.
Other Operating Expenses rose to $4.6 million in Q4 2022 per ENOV's latest filing, from -$975000.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at $33.0 million in Q3 2022 and bottomed at -$975000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Enovis	1.50 Bn	1.48 Bn	359.25 Mn

Download Data